Evaluation of Mutations in Exons 7 and 8 of TP53 Gene in Breast Cancer Patients from Azarbaijan
BACKGROUND AND OBJECTIVE: Breast cancer is the most common type of malignancy in women, and TP53 tumor-suppressor gene is one of the most commonly transformed genes in human cancers. Accurate assessment of TP53 gene mutations in cancer patients can play an important role in diagnosis, prognosis, or...
Main Authors: | N Pouladi, MA Hosseinpour feizi, H Khani |
---|---|
Format: | Article |
Language: | English |
Published: |
Babol University of Medical Sciences
2016-02-01
|
Series: | Majallah-i Dānishgāh-i ̒Ulūm-i Pizishkī-i Bābul |
Subjects: | |
Online Access: | http://jbums.org/browse.php?a_code=A-10-1062-1&slc_lang=en&sid=1 |
Similar Items
-
The single nucleotide polymorphism arg399gln rs25487 in XRCC1 gene is a breast cancer risk factor, but is not related to tp53 mutation status
by: Arghavanian Yalda, et al.
Published: (2020-01-01) -
Impact of TP53 mutations in breast cancer: Clinicopathological features and prognosisImpact of TP53 mutations in breast CA
by: Xuerui Li, et al.
Published: (2020-07-01) -
The <it>R337H </it>mutation in <it>TP53 </it>and breast cancer in Brazil
by: Gomes Magda CB, et al.
Published: (2012-03-01) -
Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patients
by: Ava Kwong, et al.
Published: (2020-11-01) -
TP53 GENE MUTATIONS – FROM GUARDIAN OF THE GENOME TO ONCOGENE
by: Petar Babović, et al.
Published: (2010-03-01)